-
Sector Analysis
New![]()
Automotive Turbochargers Market Trends and Analysis by Technology, Companies and Forecast to 2028
Automotive Turbochargers Market Report Overview The automotive turbochargers market size is estimated at 75.8 million units in 2023 and is expected to register a negative CAGR of more than 1% during 2023-2028. However, due to the growing use of turbochargers in gasoline engines, there is a significant amount of growth potential for the market. Contrary to their gasoline counterparts, almost all current diesel engine vehicles come with turbochargers. But in recent years, turbochargers have also been used in gasoline engines....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sargramostim in Hematopoietic Stem Cell Transplantation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Sargramostim in Hematopoietic Stem Cell Transplantation Drug Details: Sargramostim (Leukine, Interberin) is a recombinant granulocyte...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sargramostim in Acute Respiratory Failure
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Sargramostim in Acute Respiratory Failure Drug Details: Sargramostim (Leukine, Interberin) is a recombinant granulocyte macrophage...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sargramostim in Alzheimer’s Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Sargramostim in Alzheimer's Disease Drug Details: Sargramostim (Leukine, Interberin) is a recombinant granulocyte macrophage colony-stimulating...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sargramostim in Metastatic Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Sargramostim in Metastatic Melanoma Drug Details: Sargramostim (Leukine, Interberin) is a recombinant granulocyte macrophage colony-stimulating...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OLX-101A in Hypertrophic Scars
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OLX-101A in Hypertrophic Scars Drug Details: OLX-101A (BMT-101) is under development for the treatment...
-
Product Insights
![]()
Bath and North East Somerset Council/ BMT Group – Bath Quays South Regeneration – Somerset
Equip yourself with the essential tools needed to make informed and profitable decisions with our Bath and North East Somerset Council/ BMT Group - Bath Quays South Regeneration - Somerset report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Track & Monitor
![]()
Innovation in Ship: Cargo unloading ramps
Innovation in the ship industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in ship industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Track & Monitor
![]()
Innovation in Ship: Marine fenders
Innovation in the ship industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in ship industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Analyst Opinions
![]()
Commerce Tomorrow – How Embedded Finance is Disrupting the Modern Economy
Embedded finance is the streamlined integration of financial services into a conventional non-financial service. It is intended to simplify financial processes for consumers and provide a better user experience by allowing them to access what they need when they need it. The key enablers for embedded finance are open banking and payment application programming interfaces (APIs). While these have advanced and matured sufficiently to enable embedded finance to become viable, it is not the case in all markets indicating that...
-
Product Insights
![]()
Net Present Value Model: Neutrogin
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Neutrogin Drug Details Lenograstim (Neutrogen /...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – OLX-101A
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry OLX-101A Drug Details OLX-101A (BMT-101) is under development for the treatment of hypertrophic scar....
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – sargramostim
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry sargramostim Drug Details Sargramostim (Leukine, Interberin) is a recombinant granulocyte macrophage colony-stimulating factor (rhu...
-
Product Insights
![]()
Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Metabotropic glutamate receptor 2 (MGLUR2) is a receptor for glutamate. The ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase. The MGLUR2 pipeline market research report provides comprehensive information on the MGLUR2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...
-
Sector Analysis
![]()
Global LNG Industry Outlook to 2021 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
Global LNG Industry Outlook to 2021 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals is a comprehensive report on the global LNG industry. The report provides key asset details of all active and planned, LNG liquefaction and regasification terminals in the world by region and country. Information by terminal includes terminal name, operator name and design LNG processing capacity (liquefaction / regasification) for the period 2011–2021. Planned (new build) LNG terminals capacity additions and...
-
Sector Analysis
![]()
Global Planned LNG Industry Outlook to 2021 – Capacity and Capital Expenditure Forecasts with Details of All Planned Terminals
Global Planned LNG Industry Outlook to 2021 – Capacity and Capital Expenditure Forecasts with Details of All Planned Terminals is a comprehensive report on the global planned LNG industry. The report provides asset details of all planned LNG liquefaction and regasification terminals in the world by region and country. Information by terminal includes terminal name, operator name and design LNG processing capacity (liquefaction / regasification) for the period 2017–2021. The report provides global and regional LNG liquefaction and regasification capital...
-
Sector Analysis
![]()
Netherlands Midstream Oil and Gas Industry Outlook to 2021: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines, Underground Gas Storage and Gas Processing
Netherlands Midstream Oil and Gas Industry Outlook to 2021: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines, Underground Gas Storage and Gas Processing is a comprehensive report on midstream oil and gas industry in Netherlands. The report provides oil consumption, exports and imports from 2000 to 2020. The report also provides natural gas production, consumption, exports and imports details from 2000 to 2020. It also provides historic oil and gas reserves for the period 2000 to 2015. Further,...
-
Sector Analysis
![]()
United Kingdom Midstream Oil and Gas Industry Outlook to 2021: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines, Underground Gas Storage and Gas Processing
United Kingdom Midstream Oil and Gas Industry Outlook to 2021: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines, Underground Gas Storage and Gas Processing is a comprehensive report on midstream oil and gas industry in United Kingdom. The report provides oil production, consumption, exports and imports from 2000 to 2020. The report also provides natural gas production, consumption, exports and imports from 2000 to 2020. It also provides historic oil and gas reserves for the period 2000 to...
-
Sector Analysis
![]()
LNG Industry Outlook in Middle East and Africa to 2020 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
LNG Industry Outlook in Middle East and Africa to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals is a comprehensive report on the Middle East and Africa LNG industry. The report provides asset details of all active and planned, LNG liquefaction and regasification terminals in the region by country. Information by terminal includes terminal name, operator company name and design LNG processing capacity (liquefaction / regasification) for the period 2010-2020. Planned (new build)...
-
Sector Analysis
![]()
Global LNG Industry Outlook to 2020 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
Global LNG Industry Outlook to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals is a comprehensive report on the global LNG industry. The report provides asset details of all active and planned, LNG liquefaction and regasification terminals in the world by region and country. Information by terminal includes terminal name, operator name and design LNG processing capacity (liquefaction / regasification) for the period 2010-2020. Planned (new build) LNG terminals capacity addition and existing...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.